World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
30224
World Ranking
14022
National Ranking
461

Overview

H. Miles Prince is affiliated with the Peter MacCallum Cancer Centre in Australia. Their primary field of research lies within Medicine with a significant focus on Pathology and Forensic Medicine, Oncology, Hematology, Dermatology, and Molecular Biology.

Their research covers a broad range of topics including:

  • Lymphoma Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Cutaneous lymphoproliferative disorders research
  • CAR-T cell therapy research
  • Protein Degradation and Inhibitors
  • T-cell and Retrovirus Studies
  • Monoclonal and Polyclonal Antibodies Research

Their frequently collaborating coauthors include:

  • Carrie van der Weyden (30 coauthored works)
  • Hang Quach (24 coauthored works)
  • Belinda A. Campbell (23 coauthored works)
  • Philippe Moreau (16 coauthored works)
  • Julia Scarisbrick (15 coauthored works)

H. Miles Prince has published extensively in recognized venues. The most common publication journals include:

  • Blood (31 publications)
  • Clinical Lymphoma Myeloma & Leukemia (12 publications)
  • Internal Medicine Journal (8 publications)
  • Journal of Clinical Oncology (8 publications)
  • Leukemia & lymphoma/Leukemia and lymphoma (8 publications)

Several recent representative papers authored or coauthored by H. Miles Prince are as follows:

  • "Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results" (2023) published in Nature Medicine
  • "Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC" (2021) published in Blood
  • "Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data" (2021) published in Blood Advances
  • "T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma" (2020) published in Blood Advances
  • "Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study" (2020) published in British Journal of Dermatology

Best Publications

  • Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

    Meletios Dimopoulos;Andrew Spencer;Michael Attal;H. Miles Prince

  • Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

    Richard L. Piekarz;Robin Frye;Maria Turner;John J. Wright

  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

    Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic

  • Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

    Bertrand Coiffier;Barbara Pro;H. Miles Prince;Francine Foss

  • Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

    H Quach;D Ritchie;D Ritchie;A K Stewart;P Neeson

  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    Michel Attal;Paul G. Richardson;S. Vincent Rajkumar;Jesus San-Miguel

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

  • Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

    Richard L. Piekarz;Robin Frye;H. Miles Prince;Mark H. Kirschbaum

  • Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

    David S. Ritchie;Paul J. Neeson;Paul J. Neeson;Amit Khot;Stefan Peinert

  • EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

    Werner Kempf;Katrin Pfaltz;Maarten H. Vermeer;Antonio Cozzio

  • Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

    Andrew Spencer;H. Miles Prince;Andrew W. Roberts;Ian W. Prosser

  • Clinical studies of histone deacetylase inhibitors.

    H Miles Prince;Mark J Bishton;Simon J Harrison

  • Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients

    Roberto N. Miranda;Tariq N. Aladily;H. Miles Prince;Rashmi Kanagal-Shamanna

  • Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Julia J. Scarisbrick;H. Miles Prince;Maarten H. Vermeer;Pietro Quaglino

  • A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

    Mary E D Flowers;Jane F. Apperley;Koen Van Besien;Ahmet Elmaagacli

  • Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk

    Anna Loch-Wilkinson;Kenneth J. Beath;Robert John William Knight;William Louis Fick Wessels

  • Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

    Honghua Hu;Khalid Johani;Ahmad Almatroudi;Karen Vickery

  • Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma

    Leigh Ellis;Yan Pan;Gordon K. Smyth;Daniel J. George

  • Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study

    Anas Younes;Anna Sureda;Dina Ben-Yehuda;Pier Luigi Zinzani

  • Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

    Brian J P Huntly;Alistair G Reid;Anthony J Bench;L J Campbell

Frequent Co-Authors

John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Ricky W. Johnstone
Ricky W. Johnstone Peter MacCallum Cancer Centre
Constantine S. Tam
Constantine S. Tam University of Melbourne
Madeleine Duvic
Madeleine Duvic The University of Texas MD Anderson Cancer Center
Andrew Spencer
Andrew Spencer Monash University
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Michael H. Kershaw
Michael H. Kershaw Peter MacCallum Cancer Centre
Sean Whittaker
Sean Whittaker King's College London
Phillip K. Darcy
Phillip K. Darcy Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in exploring additional healthcare careers or enhancing your credentials, a variety of related online programs can help you get started. For those seeking leadership roles, online health administration programs can provide the skills needed to manage healthcare organizations effectively and grow in the rapidly evolving medical field.

Nurses aspiring to advance can benefit from bridge programs such as rn to np, which allow registered nurses to become nurse practitioners and take on more specialized roles in patient care. Similarly, those with a passion for nutrition and wellness can consider an online dietitian degree, preparing them for roles in hospitals, clinics, or public health settings.

For those aiming for high-level administrative positions, pursuing top cahme-accredited mha programs ensures a reputable and comprehensive education in healthcare management. These flexible online pathways make it possible for working professionals and students to continue their education and broaden their career opportunities within medicine and beyond.

Best Scientists Citing H. Miles Prince

Trending Scientists

Recently Published Articles